2025年8月19日，江苏神通(002438.SZ)发布2025年中报。 公司营业总收入为10.68亿元，较去年同报告期营业总收入增加1604.42万元，实现5年连续上涨，同比较去年同期上涨1.52%。归母净利润为1.50亿元，较去 年同报告期归母净利润增加677.44万元，实现3年连续上涨，同比较去年同期上涨4.72%。经营活动现金净流入为-3595.76万元，较去年同报告期经营活动现 金净流入增加2514.41万元。 公司摊薄每股收益为0.30元，较去年同报告期摊薄每股收益增加0.01元，实现3年连续上涨，同比较去年同期上涨4.70%。 公司最新总资产周转率为0.18次。最新存货周转率为0.81次。 公司股东户数为2.77万户，前十大股东持股数量为2.01亿股，占总股本比例为39.65%，前十大股东持股情况如下： | 序号 | 股东名称 | 持股 | | --- | --- | --- | | l | 宁波聚源瑞利创业投资合伙企业(有限合伙) | 16.2 | | 2 | 吴建新 | 8.10 | | 3 | 湖州风林火山股权投资合伙企业(有限合伙) | 5.00 | | 4 | 黄高杨 | 2.32 | ...

公司最新资产负债率为20.61%，较去年同期资产负债率减少1.16个百分点。 2025年8月19日，国瓷材料(300285.SZ)发布2025年中报。 公司营业总收入为21.54亿元，较去年同报告期营业总收入增加2.01亿元，实现5年连续上涨，同比较去年同期上涨10.29%。归母净利润为3.32亿元，较去年 同报告期归母净利润增加126.82万元，实现2年连续上涨，同比较去年同期上涨0.38%。经营活动现金净流入为3.33亿元，较去年同报告期经营活动现金净流 入增加1.79亿元，实现2年连续上涨，同比较去年同期上涨116.11%。 公司摊薄每股收益为0.33元。 公司最新总资产周转率为0.23次，较去年同期总资产周转率增加0.01次，同比较去年同期上涨6.05%。最新存货周转率为1.51次，较去年同期存货周转率增加 0.09次，实现3年连续上涨，同比较去年同期上涨6.49%。 公司股东户数为4.82万户，前十大股东持股数量为4.27亿股，占总股本比例为42.81%，前十大股东持股情况如下： | 序号 | 股东名称 | 持股 | | --- | --- | --- | | l | 张曦 | 15.3 | | 2 ...

Core Insights - The company reported a total revenue of 307 million yuan for the first half of 2025, marking an increase of 45.9 million yuan compared to the same period last year, achieving a 17.6% year-on-year growth [1] - The net profit attributable to shareholders reached 108 million yuan, an increase of 40.1 million yuan from the previous year, reflecting a 59.01% year-on-year growth [1] - The net cash inflow from operating activities was 118 million yuan [1] Financial Metrics - The latest debt-to-asset ratio stands at 11.01% [3] - The gross profit margin is 49.68%, up 0.92 percentage points from the previous quarter, and has increased by 7.59 percentage points year-on-year [3] - The return on equity (ROE) is 6.64%, an increase of 2.14 percentage points compared to the same period last year [3] - The diluted earnings per share (EPS) is 0.64 yuan, up 0.24 yuan year-on-year, representing a 60% increase [3] - The total asset turnover ratio is 0.17 times, an increase of 0.01 times year-on-year, reflecting an 8.35% growth [3] - The inventory turnover ratio is 0.99 times [3] Shareholder Structure - The number of shareholders is 8,278, with the top ten shareholders holding a total of 90.09 million shares, accounting for 53.53% of the total share capital [3] - The largest shareholder is Wuhan Xiwang Biological Engineering Co., Ltd., holding 44.1% of the shares [3]

Core Insights - The company reported a total revenue of 2.573 billion yuan for the first half of 2025, marking an increase of 861 million yuan and a year-on-year growth of 50.25% [1] - The net profit attributable to shareholders reached 216 million yuan, an increase of 32.17 million yuan, reflecting a year-on-year growth of 17.54% [1] - The company has achieved three consecutive years of revenue and profit growth [1] Financial Performance - The latest asset-liability ratio stands at 56.11% [3] - The gross profit margin is reported at 26.15% [3] - The return on equity (ROE) is 7.16%, which is an increase of 0.07 percentage points compared to the same period last year [3] - The diluted earnings per share (EPS) is 0.22 yuan, up by 0.03 yuan, representing a year-on-year increase of 15.79% [3] - The total asset turnover ratio is 0.40 times, an increase of 0.06 times year-on-year, reflecting a growth of 16.35% [3] - The inventory turnover ratio is 1.79 times, up by 0.06 times, indicating a year-on-year increase of 3.38% [3] Shareholder Structure - The number of shareholders is 71,500, with the top ten shareholders holding 511 million shares, accounting for 52.72% of the total share capital [3] - The largest shareholder is Shenzhen Yingweike Investment Co., Ltd., holding 25.29% of the shares [3] - Other notable shareholders include Hong Kong Central Clearing Limited (8.49%) and Qi Yong (5.69%) [3]

Core Insights - The company reported a total revenue of 8.547 billion yuan for the first half of 2025, an increase of 1.661 billion yuan compared to the same period last year, representing a year-on-year growth of 24.13% [1] - The net profit attributable to shareholders reached 26.4349 million yuan, an increase of 69.4684 million yuan from the same period last year, marking two consecutive years of growth [1] - The net cash inflow from operating activities was 454 million yuan, up by 136 million yuan year-on-year, also achieving two consecutive years of increase with a year-on-year growth of 42.61% [1] Financial Metrics - The latest debt-to-asset ratio stands at 56.80% [3] - The gross profit margin is 2.10%, an increase of 0.17 percentage points from the same period last year, achieving two consecutive years of growth [3] - The return on equity (ROE) is 0.31%, an increase of 0.81 percentage points year-on-year [3] - The diluted earnings per share (EPS) is 0.03 yuan, an increase of 0.08 yuan from the same period last year, marking two consecutive years of growth [3] - The total asset turnover ratio is 0.44 times, an increase of 0.06 times year-on-year, representing a growth of 15.93% [3] - The inventory turnover ratio is 5.50 times [3] Shareholder Structure - The number of shareholders is 33,100, with the top ten shareholders holding a total of 476 million shares, accounting for 56.09% of the total share capital [3] - The largest shareholder, Qin Qingping, holds 37.49% of the shares [3] - Other significant shareholders include Zhongyue Capital Management Co., Ltd. with 10.20% and Ren Yongmei with 1.95% [3]

Core Insights - The company reported a total revenue of 440 million yuan for the first half of 2025, an increase of 210 million yuan compared to the same period last year, marking a 91.53% year-on-year growth [1] - The net profit attributable to shareholders reached 30.69 million yuan, up by 37.82 million yuan from the previous year, achieving two consecutive years of growth [1] - The net cash inflow from operating activities was 56.70 million yuan, an increase of 54.57 million yuan year-on-year, also reflecting two consecutive years of growth [1] Financial Ratios - The latest debt-to-asset ratio stands at 18.97% [3] - The gross profit margin is 24.74%, which is an increase of 6.53 percentage points compared to the same period last year [3] - The return on equity (ROE) is 2.49%, up by 3.08 percentage points year-on-year [3] Earnings Per Share and Turnover Ratios - The diluted earnings per share is 0.20 yuan, an increase of 0.25 yuan compared to the same period last year, achieving two consecutive years of growth [3] - The total asset turnover ratio is 0.30 times, an increase of 0.14 times year-on-year, reflecting an 81.89% increase [3] - The inventory turnover ratio is 2.85 times, up by 0.46 times compared to the previous year, representing a 19.20% year-on-year increase [3] Shareholder Information - The number of shareholders is 8,831, with the top ten shareholders holding a total of 95.10 million shares, accounting for 62.61% of the total share capital [3] - The largest shareholder, Luo Xingshun, holds 34.33% of the shares [3]

Core Insights - Han Yu Group (300403.SZ) reported a total operating revenue of 572 million yuan for the first half of 2025, marking an increase of 20.03 million yuan compared to the same period last year, achieving a 3.63% year-on-year growth [1] - The net profit attributable to shareholders reached 117 million yuan, an increase of 514,500 yuan year-on-year, reflecting a 0.44% growth compared to the same period last year [1] - The net cash inflow from operating activities was 114 million yuan, up by 3.32% year-on-year, with an increase of 3.66 million yuan compared to the same period last year [1] Financial Ratios - The latest debt-to-asset ratio stands at 15.26%, a decrease of 1.26 percentage points from the previous quarter and a reduction of 2.76 percentage points year-on-year [3] - The latest gross profit margin is 33.56% [3] - The return on equity (ROE) is reported at 5.55% [3] Earnings Per Share and Turnover - The diluted earnings per share remained stable compared to the same period last year, with a year-on-year increase of 0.41% [3] - The total asset turnover ratio is 0.23 times, while the inventory turnover ratio is 1.52 times, which is an increase of 0.02 times year-on-year, reflecting a 1.44% growth [3] Shareholder Information - The number of shareholders is 61,400, with the top ten shareholders holding a total of 257 million shares, accounting for 42.54% of the total share capital [3] - The top shareholders include Shi Huashan with 34.3 million shares, Shi Lei with 3.05 million shares, and Wu Geming with 1.68 million shares [3]

公司最新资产负债率为48.47%。 2025年8月16日，中路股份(600818.SH)发布2025年中报。 公司最新毛利率为14.93%。最新ROE为-1.46%。 公司营业总收入为5.74亿元，较去年同报告期营业总收入增加5526.90万元，实现5年连续上涨，同比较去年同期上涨10.66%。归母净利润为-830.91万元。经 营活动现金净流入为930.64万元，较去年同报告期经营活动现金净流入增加2066.95万元。 公司摊薄每股收益为-0.03元。 公司最新总资产周转率为0.59次，较去年同期总资产周转率持平，实现4年连续上涨，同比较去年同期上涨0.61%。最新存货周转率为8.42次，较去年同期存 货周转率增加0.06次，同比较去年同期上涨0.72%。 公司股东户数为4.19万户，前十大股东持股数量为4168.65万股，占总股本比例为12.97%，前十大股东持股情况如下： | 序号 | 股东名称 | 持股 | | --- | --- | --- | | l | 上海中路(集团)有限公司 | 7.05 | | 2 | 郭洪涛 | 1.66 | | 3 | 李文武 | 1.04 | | 4 | 牛佳伟 | ...

Financial Performance - The company reported a total revenue of 513 million yuan, an increase of 48.43 million yuan compared to the same period last year, achieving a year-on-year growth of 10.43% [1] - The net profit attributable to shareholders was 73.38 million yuan, up by 3.51 million yuan year-on-year, marking a 5.03% increase [1] - The net cash inflow from operating activities was 118 million yuan, an increase of 16.96 million yuan year-on-year, representing a growth of 16.83% [1] Profitability Metrics - The latest asset-liability ratio stands at 20.29% [3] - The gross profit margin is 28.58%, up by 1.77 percentage points from the previous quarter and 1.24 percentage points from the same period last year [3] - The return on equity (ROE) is 4.22%, an increase of 0.16 percentage points year-on-year [3] - The diluted earnings per share (EPS) is 0.50 yuan, an increase of 0.03 yuan year-on-year, reflecting a growth of 7.45% [3] Efficiency Ratios - The total asset turnover ratio is 0.24 times, an increase of 0.01 times year-on-year, representing a growth of 6.24% [3] - The inventory turnover ratio is 1.70 times, up by 0.18 times year-on-year, achieving an 11.83% increase [3] Shareholder Structure - The number of shareholders is 19,000, with the top ten shareholders holding 97.82 million shares, accounting for 65.39% of the total share capital [3] - The largest shareholder, Xiong Ying, holds 24.84% of the shares, followed by Xiong Jie with 20.41% [3]

Financial Performance - The total revenue for Huarun Pharmaceutical in the first half of 2025 was 624 million yuan, a decrease of 148 million yuan compared to the same period last year, representing a year-on-year decline of 19.13% [1] - The net profit attributable to shareholders was 37.33 million yuan, down 35.88 million yuan from the same period last year, reflecting a year-on-year decrease of 49.01% [1] - The net cash inflow from operating activities was 170 million yuan, an increase of 8.53 million yuan compared to the same period last year, marking a 5.29% year-on-year increase and achieving four consecutive years of growth [1] Profitability and Efficiency Ratios - The latest asset-liability ratio is 58.74%, a decrease of 0.96 percentage points from the previous quarter, but an increase of 15.25 percentage points compared to the same period last year [3] - The latest gross profit margin is 37.73%, an increase of 1.44 percentage points from the previous quarter, achieving two consecutive quarters of growth, but a slight decrease of 0.02 percentage points compared to the same period last year [3] - The latest return on equity (ROE) is 2.79%, an increase of 0.12 percentage points compared to the same period last year [3] - The diluted earnings per share are 0.03 yuan, a decrease of 0.03 yuan compared to the same period last year, reflecting a year-on-year decline of 48.95% [3] - The latest total asset turnover ratio is 0.18 times, an increase of 0.03 times compared to the same period last year, representing a year-on-year increase of 19.72% [3] - The latest inventory turnover ratio is 1.30 times, a decrease of 0.17 times compared to the same period last year, reflecting a year-on-year decline of 11.46% [3] Shareholder Structure - The number of shareholders is 42,000, with the top ten shareholders holding 529 million shares, accounting for 44.77% of the total share capital [3] - The largest shareholder is Xi'an Qujiang Tian Shou Health Investment Partnership, holding 20.00% of the shares [3]